Telomir Pharmaceuticals, Inc.
TELO
Revenue
0.00
0.000.00%
-Assets
2.10M
▼-1.40M▼-40.00%
3 Months ChangeLiabilities
534.16k
▲47.60k▲9.78%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001493152-24-038530
2024-09-03
Form 8-K
ID: 0001493152-24-034831
2024-08-13
Form 10-Q
ID: 0001493152-24-031606
2024-06-24
Form 8-K
ID: 0001493152-24-024812
2024-05-13
Form 10-Q
ID: 0001493152-24-018909
2024-04-15
Form 8-K
ID: 0001493152-24-014616
2024-04-12
Form 8-K
ID: 0001493152-24-014446
2024-02-13
Form 8-K
ID: 0001493152-24-006094